T cell receptor signalling in the control of regulatory T cell differentiation and function

Nature Reviews Immunology

Volumn 16, Issue 4, 2016, Pages 220-233

  Li, Ming O ^a   Rudensky, Alexander Y ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; DIFFERENTIATION ANTIGEN; NUCLEAR RECEPTOR NUR77; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ACCESSORY CELL; ANTIBODY AFFINITY; BINDING AFFINITY; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; COMMENSAL; EPIGENETICS; HUMAN; LYMPHOCYTE FUNCTION; MOLECULAR BIOLOGY; NEOPLASM; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

CELL DIFFERENTIATION; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL; SELF TOLERANCE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 84978634373     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri.2016.26     Document Type: Review

References (151)

1. Burnet, F. M. The Clonal Selection Theory of Acquired Immunity (Vanderbilt Univ. Press, 1959).
2. Josefowicz, S. Z., Lu, L. F. & Rudensky, A. Y. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531-564 (2012).
3. Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775-787 (2008).
4. Nishizuka, Y. Thymus and reproduction: sex-linked dysgnesia of the gonad after neonatal thymectomy in mice. Science 166, 753-755 (1969).
5. Sakaguchi, S., Fukuma, K., Kuribayashi, K. & Masuda, T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161, 72-87 (1985).
6. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303-310 (2000).
7. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164 (1995).
8. + T cells induce or protect from chronic intestinal inflammation in C. B-17 SCID mice. Int. Immunol. 5, 1461-1471 (1993).
9. + T cells. J. Exp. Med. 178, 237-244 (1993).
10. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
11. + regulatory T cells. Nat. Immunol. 4, 330-336 (2003).
12. + T regulatory cells. Nat. Immunol. 4, 337-342 (2003).
13. Fontenot, J. D. et al. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22, 329-341 (2005).
14. Gavin, M. A. et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445, 771-775 (2007).
15. Lin, W. et al. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8,359-368 (2007).
16. Luo, C. T. & Li, M. O. Transcriptional control of regulatory T cell development and function. Trends Immunol. 34, 531-539 (2013).
17. Moran, A. E. et al. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J. Exp. Med. 208, 1279-1289 (2011).
18. Hsieh, C. S., Zheng, Y., Liang, Y., Fontenot, J. D. & Rudensky, A. Y. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat. Immunol. 7, 401-410 (2006).
19. Lafaille, J. J., Nagashima, K., Katsuki, M. & Tonegawa, S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78, 399-408 (1994).
20. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2, 301-306 (2001).
21. Apostolou, I., Sarukhan, A., Klein, L. & von Boehmer, H. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3, 756-763 (2002).
22. + regulatory T cell formation requires more specific recognition of a self-peptide than thymocyte deletion. Proc. Natl Acad. Sci. USA 108, 14890-14895 (2011).
23. Lee, H. M., Bautista, J. L., Scott-Browne, J., Mohan, J. F. & Hsieh, C. S. A broad range of self-reactivity drives thymic regulatory T cell selection to limit responses to self. Immunity 37, 475-486 (2012).
24. Paiva, R. S. et al. Recent thymic emigrants are the preferential precursors of regulatory T cells differentiated in the periphery. Proc. Natl Acad. Sci. USA 110, 6494-6499 (2013).
25. Apostolou, I. & von Boehmer, H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199, 1401-1408 (2004).
26. Kretschmer, K. et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6, 1219-1227 (2005).
27. Gottschalk, R. A., Corse, E. & Allison, J. P. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J. Exp. Med. 207, 1701-1711 (2010).
28. + T cells in two major waves of thymic deletion distinguished by induction of PD-1 or NF-κB. J. Exp. Med. 210, 269-285 (2013).
29. Stritesky, G. L. et al. Murine thymic selection quantified using a unique method to capture deleted T cells. Proc. Natl Acad. Sci. USA 110, 4679-4684 (2013).
30. Fontenot, J. D., Dooley, J. L., Farr, A. G. & Rudensky, A. Y. Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 202, 901-906 (2005).
31. + thymocyte development. J. Exp. Med. 210, 675-681 (2013).
32. Mathis, D. & Benoist, C. Aire. Annu. Rev. Immunol. 27, 287-312 (2009).
33. + medullary thymic epithelial cells. Nat. Immunol. 8, 351-358 (2007).
34. Yang, S., Fujikado, N., Kolodin, D., Benoist, C. & Mathis, D. Immune tolerance. Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance. Science 348, 589-594 (2015).
35. Tanaka, S. et al. Graded attenuation of TCR signaling elicits distinct autoimmune diseases by altering thymic T cell selection and regulatory T cell function. J. Immunol. 185, 2295-2305 (2010).
36. Siggs, O. M. et al. Opposing functions of the T cell receptor kinase ZAP-70 in immunity and tolerance differentially titrate in response to nucleotide substitutions. Immunity 27, 912-926 (2007).
37. Hsu, L. Y., Tan, Y. X., Xiao, Z., Malissen, M. & Weiss, A. A hypomorphic allele of ZAP-70 reveals a distinct thymic threshold for autoimmune disease versus autoimmune reactivity. J. Exp. Med. 206, 2527-2541 (2009).
38. + regulatory T cell development. J. Exp. Med. 203, 119-129 (2006).
39. Fu, G. et al. Phospholipase Cγ1 is essential for T cell development, activation, and tolerance. J. Exp. Med. 207, 309-318 (2010).
40. Oh-hora, M. et al. Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat. Immunol. 9, 432-443 (2008).
41. + regulatory and natural killer-like T cells on signals leading to NF-κB activation. Proc. Natl Acad. Sci. USA 101, 4566-4571 (2004).
42. Gupta, S. et al. Differential requirement of PKC-θ in the development and function of natural regulatory T cells. Mol. Immunol. 46, 213-224 (2008).
43. Medoff, B. D. et al. Differential requirement for CARMA1 in agonist-selected T-cell development. Eur. J. Immunol. 39, 78-84 (2009).
44. Barnes, M. J. et al. Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. PLoS Biol. 7, e51 (2009).
45. Chen, X., Priatel, J. J., Chow, M. T. & Teh, H. S. Preferential development of CD4 and CD8 T regulatory cells in RasGRP1-deficient mice. J. Immunol. 180, 5973-5982 (2008).
46. Willoughby, J. E. et al. Raf signaling but not the ERK effector SAP-1 is required for regulatory T cell development. J. Immunol. 179, 6836-6844 (2007).
47. Schmidt, A. M. et al. Diacylglycerol kinase ξ limits the generation of natural regulatory T cells. Sci. Signal. 6, ra101 (2013).
48. Joshi, R. P. et al. The ξ isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated Ras signaling. Sci. Signal. 6, ra102 (2013).
49. Long, M., Park, S.-G., Strickland, I., Hayden, M. S. & Ghosh, S. Nuclear factor-κB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. Immunity 31, 921-931 (2009).
50. Fassett, M. S., Jiang, W., D'Alise, A. M., Mathis, D. & Benoist, C. Nuclear receptor Nr4a1 modulates both regulatory T-cell (Treg) differentiation and clonal deletion. Proc. Natl Acad. Sci. USA 109, 3891-3896 (2012).
51. Hwang, S. et al. Reduced TCR signaling potential impairs negative selection but does not result in autoimmune disease. J. Exp. Med. 209, 1781-1795 (2012).
52. Park, Y. et al. SHARPIN controls regulatory T cells by negatively modulating the T cell antigen receptor complex. Nat. Immunol. 17, 286-296 (2016).
53. + cells. J. Exp. Med. 205, 565-574 (2008).
54. + regulatory T cells. J. Immunol. 177, 6598-6602 (2006).
55. Chang, X., Lazorchak, A. S., Liu, D. & Su, B. Sin1 regulates Treg-cell development but is not required for T-cell growth and proliferation. Eur. J. Immunol. 42, 1639-1647 (2012).
56. Sauer, S. et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl Acad. Sci. USA 105, 7797-7802 (2008).
57. + regulatory T cells. Nat. Immunol. 11, 618-627 (2010).
58. Lio, C.-W. J. & Hsieh, C.-S. A. Two-step process for thymic regulatory T cell development. Immunity 28, 100-111 (2008).
59. + regulatory T cells. J. Immunol. 178, 280-290 (2007).
60. Bautista, J. L. et al. Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat. Immunol. 10, 610-617 (2009).
61. + cells is limited to small clonal sizes. J. Exp. Med. 206, 2121-2130 (2009).
62. Le Borgne, M. et al. The impact of negative selection on thymocyte migration in the medulla. Nat. Immunol. 10, 823-830 (2009).
63. + T cell tolerance. Nat. Immunol. 11, 512-519 (2010).
64. Ouyang, W. & Li, M. O. Foxo: in command of T lymphocyte homeostasis and tolerance. Trends Immunol. 32, 26-33 (2011).
65. + regulatory T cells is driven by the c-Rel enhanceosome. Immunity 31, 932-940 (2009).
66. + regulatory T cells. Proc. Natl Acad. Sci. USA 109, 16258-16263 (2012).
67. Gomez-Rodriguez, J. et al. Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells. J. Exp. Med. 211, 529-543 (2014).
68. Huang, W., Jeong, A. R., Kannan, A. K., Huang, L. & August, A. IL-2-inducible T cell kinase tunes T regulatory cell development and is required for suppressive function. J. Immunol. 193, 2267-2272 (2014).
69. Chi, H. Regulation and function of mTOR signalling in T cell fate decisions. Nat. Rev. Immunol. 12, 325-338 (2012).
70. Delgoffe, G. M. et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30, 832-844 (2009).
71. Yun, T. J. & Bevan, M. J. The Goldilocks conditions applied to T cell development. Nat. Immunol. 2, 13-14 (2001).
72. Tai, X., Cowan, M., Feigenbaum, L. & Singer, A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6, 152-162 (2005).
73. Hinterberger, M., Wirnsberger, G. & Klein, L. B7/CD28 in central tolerance: costimulation promotes maturation of regulatory T cell precursors and prevents their clonal deletion. Front. Immunol. 2, 30 (2011).
74. + regulatory T cell development via the CD27-CD70 pathway. J. Exp. Med. 210, 715-728 (2013).
75. Mahmud, S. A. et al. Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells. Nat. Immunol. 15, 473-481 (2014).
76. Benson, M. J., Pino-Lagos, K., Rosemblatt, M. & Noelle, R. J. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204, 1765-1774 (2007).
77. + cells in the absence of CD5 signaling. Eur. J. Immunol. 39, 2233-2247 (2009).
78. Henderson, J. G., Opejin, A., Jones, A., Gross, C. & Hawiger, D. CD5 instructs extrathymic regulatory T cell development in response to self and tolerizing antigens. Immunity 42, 471-483 (2015).
79. + regulatory cells. J. Immunol. 176, 3321-3329 (2006).
80. Francisco, L. M. et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206, 3015-3029 (2009).
81. Ouyang, W., Beckett, O., Ma, Q. & Li, M. O. Transforming growth factor-β signaling curbs thymic negative selection promoting regulatory T cell development. Immunity 32, 642-653 (2010).
82. Tai, X. et al. Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity 38, 1116-1128 (2013).
83. + regulatory T cells. Nat. Immunol. 9, 632-640 (2008).
84. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
85. Yao, Z. et al. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 109, 4368-4375 (2007).
86. Li, M. O. & Flavell, R. A. TGF-β: a master of all T cell trades. Cell 134, 392-404 (2008).
87. Liao, W., Lin, J. X. & Leonard, W. J. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38, 13-25 (2013).
88. Zheng, Y. et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808-812 (2010).
89. + CD4 regulatory T cells. J. Exp. Med. 206, 3001-3014 (2009).
90. Harada, Y. et al. Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J. Exp. Med. 207, 1381-1391 (2010).
91. NS protein mediates regulatory T cell development via induction of the Foxp3 transcription factor. Immunity 37, 998-1008 (2012).
92. Tone, Y. et al. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9, 194-202 (2008).
93. Sekiya, T. et al. Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. Nat. Immunol. 14, 230-237 (2013).
94. Gao, P. et al. Dynamic changes in E-protein activity regulate T reg cell development. J. Exp. Med. 211, 2651-2668 (2014).
95. Liu, C. et al. Id1 expression promotes T regulatory cell differentiation by facilitating TCR costimulation. J. Immunol. 193, 663-672 (2014).
96. H17 cells by the DNA-binding inhibitor Id3. Nat. Immunol. 12, 86-95 (2011).
97. Feng, Y. et al. A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance. Nature 528, 132-136 (2015).
98. Samstein, R. M. et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151, 153-166 (2012).
99. Ohkura, N. et al. T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 37, 785-799 (2012).
100. Kim, H. P. & Leonard, W. J. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J. Exp. Med. 204, 1543-1551 (2007).
101. Floess, S. et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5, e38 (2007).
102. Josefowicz, S. Z., Wilson, C. B. & Rudensky, A. Y. Cutting edge: TCR stimulation is sufficient for induction of Foxp3 expression in the absence of DNA methyltransferase 1. J. Immunol. 182, 6648-6652 (2009).
103. Di Ruscio, A. et al. DNMT1-interacting RNAs block gene-specific DNA methylation. Nature 503, 371-376 (2013).
104. Stritesky, G. L., Jameson, S. C. & Hogquist, K. A. Selection of self-reactive T cells in the thymus. Annu. Rev. Immunol. 30, 95-114 (2012).
105. + T cells expressing the FoxP3 transcription factor. Immunity 30, 899-911 (2009).
106. + regulatory T cells. J. Exp. Med. 199, 303-313 (2004).
107. Smigiel, K. S. et al. CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets. J. Exp. Med. 211, 121-136 (2014).
108. Cheroutre, H., Lambolez, F. & Mucida, D. The light and dark sides of intestinal intraepithelial lymphocytes. Nat. Rev. Immunol. 11, 445-456 (2011).
109. Hogquist, K. A. & Jameson, S. C. The self-obsession of T cells: how TCR signaling thresholds affect fate 'decisions' and effector function. Nat. Immunol. 15, 815-823 (2014).
110. + suppressor T cells in vivo. Nat. Immunol. 3, 33-41 (2002).
111. + T regulatory cells. Blood 109, 2014-2022 (2007).
112. + T cells. Blood 119, 5155-5163 (2012).
113. + regulatory T cells in the regional lymph node. J. Exp. Med. 202, 771-781 (2005).
114. Luo, C. T., Liao, W., Dadi, S., Toure, A. & Li, M. O. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature 529, 532-536 (2016).
115. Rosenblum, M. D. et al. Response to self antigen imprints regulatory memory in tissues. Nature 480, 538-542 (2011).
116. Levine, A. G., Arvey, A., Jin, W. & Rudensky, A. Y. Continuous requirement for the TCR in regulatory T cell function. Nat. Immunol. 15, 1070-1078 (2014).
117. Vahl, J. C. et al. Continuous T cell receptor signals maintain a functional regulatory T cell pool. Immunity 41, 722-736 (2014).
118. Feng, Y. et al. Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus. Cell 158, 749-763 (2014).
119. Li, X., Liang, Y., LeBlanc, M., Benner, C. & Zheng, Y. Function of a Foxp3 cis-element in protecting regulatory T cell identity. Cell 158, 734-748 (2014).
120. Chuck, M. I., Zhu, M., Shen, S. & Zhang, W. The role of the LAT-PLC-γ1 interaction in T regulatory cell function. J. Immunol. 184, 2476-2486 (2010).
121. Chang, J. H. et al. Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells. Nat. Immunol. 13, 481-490 (2012).
122. reg-cell function. Nature 499, 485-490 (2013).
123. + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl Acad. Sci. USA 105, 10113-10118 (2008).
124. Au-Yeung, B. B. et al. A genetically selective inhibitor demonstrates a function for the kinase Zap70 in regulatory T cells independent of its catalytic activity. Nat. Immunol. 11, 1085-1092 (2010).
125. reg cell function. Nature 491, 554-559 (2012).
126. FH cell responses. Nat. Immunol. 16, 178-187 (2015).
127. reg cells maintains homeostasis and lineage stability. Nat. Immunol. 16, 188-196 (2015).
128. + regulatory T cells. J. Exp. Med. 204, 735-745 (2007).
129. Liu, Z. et al. Immune homeostasis enforced by co-localized effector and regulatory T cells. Nature 528, 225-230 (2015).
130. + tumor-infiltrating lymphocytes in cancer: a critical review of the literature. Clin. Cancer Res. 18, 3022-3029 (2012).
131. Hindley, J. P. et al. Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors. Cancer Res. 71, 736-746 (2011).
132. Sainz-Perez, A., Lim, A., Lemercier, B. & Leclerc, C. The T-cell receptor repertoire of tumor-infiltrating regulatory T lymphocytes is skewed toward public sequences. Cancer Res. 72, 3557-3569 (2012).
133. Malchow, S. et al. Aire-dependent thymic development of tumor-associated regulatory T cells. Science 339, 1219-1224 (2013).
134. 3K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer. Nature 510, 407-411 (2014).
135. Erlebacher, A., Vencato, D., Price, K. A., Zhang, D. & Glimcher, L. H. Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J. Clin. Invest. 117, 1399-1411 (2007).
136. Rowe, J. H., Ertelt, J. M., Xin, L. & Way, S. S. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature 490, 102-106 (2012).
137. Samstein, R. M., Josefowicz, S. Z., Arvey, A., Treuting, P. M. & Rudensky, A. Y. Extrathymic generation of regulatory T cells in pacental mammals mitigates maternal-fetal conflict. Cell 150, 29-38 (2012).
138. Aluvihare, V. R., Kallikourdis, M. & Betz, A. G. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5, 266-271 (2004).
139. Zenclussen, A. C. et al. Regulatory T cells induce a privileged tolerant microenvironment at the fetal-maternal interface. Eur. J. Immunol. 36, 82-94 (2006).
140. Mold, J. E. et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 322, 1562-1565 (2008).
141. Kinder, J. M. et al. Cross-generational reproductive fitness enforced by microchimeric maternal cells. Cell 162, 505-515 (2015).
142. Lathrop, S. K. et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 478, 250-254 (2011).
143. Cebula, A. et al. Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature 497, 258-262 (2013).
144. Atarashi, K. et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232-236 (2013).
145. Schlenner, S. M., Weigmann, B., Ruan, Q., Chen, Y. & von Boehmer, H. Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut. J. Exp. Med. 209, 1529-1535 (2012).
146. Josefowicz, S. Z. et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482, 395-399 (2012).
147. Zeiser, R. et al. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood 111, 453-462 (2008).
148. Klatzmann, D. & Abbas, A. K. The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases. Nat. Rev. Immunol. 15,283-294 (2015).
149. Simpson, T. R. et al. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. J. Exp. Med. 210, 1695-1710 (2013).
150. Bulliard, Y. et al. Activating Fcγ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies. J. Exp. Med. 210, 1685-1693 (2013).
151. Selby, M. J. et al. Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells. Cancer Immunol. Res. 1, 32-42 (2013).